BSECompany Update5 Aug 2026 · 5 Aug 2026, 05:57 pm

Re-appointment of Mr. Hemang Shah as Executive Director of the Company, Subject to approval of Shareholders in enuing AGM.

Bharat Parenterals Ltd · 541096

✦ AI SummaryMgmt Change

Bharat Parenterals Ltd has announced the re-appointment of Mr. Hemang Shah as Executive Director of the company, subject to shareholder approval at the upcoming AGM.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Change in Directorate

Attachments (1)

📄

262faf1c-a3eb-4deb-b3ca-31bee66d8823.pdf

pdf

Download →
View document text
Date: August 05, 2026 The Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001. Script Code: 541096 Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Re-Appointment of Mr. Hemang Shah As An Executive Director of the Company. Pursuant to Regulation 30 of the SEBI LODR Regulations, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. August 05, 2026 has inter alia based on recommendation of Nomination and Remuneration Committee, Audit Committee and subject to the approval of shareholders at the ensuing Annual General Meeting, approved the re-appointment of Mr. Hemang Shah (DIN: 03024324) as an Executive Director of the Company for the term of 5 (five) consecutive years with effect from July 02, 2026 to upto July 01, 2031. Further, we wish to inform you that the Nomination and Remuneration Committee and the Board while considering his Re-appointment, have verified that all above said person is not debarred from holding the office of Director pursuant to any order of MCA/SEBI or of any other authorities. Further, the details as required in terms of Regulation 30 read with Schedule III of the SEBI LODR Regulations and SEBI Master Circular bearing No. HO/49/14/14(7)2025- CFDPOD2/I/3762/2026 dated January 30, 2026 is provided in Annexure A. The above information will be available on the Company's website at www.bplindia.in. Kindly take the above information on record and acknowledge the receipt. Thanking You. Yours Faithfully For, Bharat Parenterals Limited Mr. Sharmin Soni Company Secretary & Compliance Officer ICSI Membership Number: A-75694 Place: Vadodara Annexure A Sr. Particular Details 1 Name Hemang Jayendrabhai Shah 2 Reason for Change viz., appointment, Re- appointment of Mr. Hemang Re-Appointment resignation, removal, Shah as an Executive Director of death or otherwise the Company. 3 Date of appointment/ Re-Appointment Date of Re- Appointment: /cessation (as applicable) & term of July 02, 2026 appointment Term of Re- Appointment: 5 (Five) consecutive years with effect from July 02, 2026 upto July 01, 2031 4 Brief Profile (in case of appointment) Mr. Hemang Shah is Bachelor of Commerce and also holds degree of MSW. He is associated with the Company from more than last Two Decade and has played a pivotal role in the growth and development of the Company. Mr. Shah has more than 30 years of reach experience. 5 Disclosure of relationships between Mr. Hemang Shah is not related to directors in case of appointment of a any Director of the Company. director.